Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma

Virchows Archiv

Volumn 432, Issue 4, 1998, Pages 337-342

  Kuhnen, Cornelius ^a   Tolnay, Edina ^a   Steinau, Hans Ulrich ^a   Voss, Bruno ^b   Müller, Klaus Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Prof Associations' Res Inst O   (Germany)

Author keywords

c Met receptor; Epithelioid sarcoma; Hepatocyte growth factor scatter factor; Synovial sarcoma

Indexed keywords

MESSENGER RNA; SCATTER FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIOID SARCOMA; EPITHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; ONCOGENE; ONCOGENE C MET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNOVIAL SARCOMA; TUMOR CELL;

HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROTO-ONCOGENE PROTEINS C-MET; SARCOMA; SARCOMA, SYNOVIAL;

EID: 0031944886     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050175     Document Type: Article

References (36)

1. Annen K, Nojima T, Hata Y, Uchino J, Tanaka S, Matsuda M, Tahara E, Nagashima K (1995) Analysis of the hepatocyte growth factor receptor in regeneration and oncogenesis of the liver. Gen Diagn Pathol 141:179-186
2. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery J-P, Jouanneau J (1994) Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9:1091-1099
3. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804
4. Comoglio PM (1993) Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. In: Goldberg ID, Rosen EM (eds) Hepatocyte growth factor-scatter factor (HGF-SF) and the c-Met receptor. Birkhäuser, Basel Boston Berlin, pp 131-165
5. Cordell JL, Falini B, Erber WN (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem 32:219-229
6. Cortner J, Vande Woude GF, Rong S (1995) The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis. In: Goldberg ID, Rosen EM (eds) Epithelial-mesenchymal interactions in cancer. Birkhäuser, Basel Boston Berlin, pp 89-121
7. Dean M, O'Connell P, Leppert M, Park M, Amos JA, Phillips DG, White R, Vande Woude GF (1987) Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis. J Pediatr 111:490-495
8. Di Renzo M, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM (1991) Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6:1997-2003
9. Di Renzo M, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S, Belfiore A, Constantino A, Vigneri R, Pierotti MA, Comoglio PM (1992) Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7:2549-2553
10. Ebert M, Yokoyama M, Friess H, Büchler MW, Korc M (1994) Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Research 54:5775-5778
11. Enzinger FM, Weiss SW (1995) Soft tissue tumors, 3rd edn. Mosby, St Louis Baltimore Berlin
12. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini PL, Cremona O, Campanacci M, Comoglio PM (1995) The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10:739-749
13. Giordano S, Di Renzo M, Narsimhan RP, Tamagnone L, Gerbaudo EV, Chiado PL, Comoglio PM (1988) Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line. J Cell Biochem 38:229-236
14. Jeffers M, Rong S, Vande Woude GF (1996) Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16:1115-1125
15. Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID, Rosen EM (1997) Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79:749-760
16. Johnson GD, De Noguera C, Aranjo JGM (1986) A simple method for reducing the fading of immunfluorescence during microscopy. J Immunol Methods 43:349-350
17. Katenkamp D, Stiller D (1990) Weichgewebstumoren: Pathologie, histologische Diagnostik und Differentialdiagnose. Johann Ambrosius Barth, Leipzig
18. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E (1992) Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 189:227-232
19. Li Q, Weng J, Mohan RR, Bennett GL, Schwall R, Wang Z-F, Tabor K, Kim J, Hargrave S, Cuevas KH, Wilson SE (1996) Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci 37:727-739
20. Liu C, Park M, Tsao MS (1992) Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erB-2 in primary human colorectal carcinomas. Oncogene 7:181-185
21. Matsumoto K, Ziober BL, Yao C-C, Kramer RH (1995) Growth factor regulation of integrin-mediated cell motility. Cancer Metastasis Rev 14:205-217
22. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, Di Renzo MF (1996) Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer [Pred Oncol] 69:212-217
23. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LWK (1995) C-met proto-oncogene expression in benign and malignant human prostate tissue. J Urol 154:293-298
24. Polverini PJ, Nickoloff BJ (1995) Role of scatter factor and the c-met protooncogene in the pathogenesis of AIDS-associated Kaposi's sarcoma. Adv Cancer Res 66:235-253
25. Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF (1993) Met expression and sarcoma tumorigenicity. Cancer Res 15:5355-5360
26. Rosen EM, Goldberg ID (1995) Scatter factor and angiogenesis. Adv Cancer Res 67:257-279
27. Rosen EM, Knesel J, Goldberg ID, Jin L, Bhargava M, Joseph A, Zitnik R, Wines J, Kelley M, Rockwell S (1994) Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer 57:706-714
28. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschlesche W, Sharpe M, Gherardi B, Birchmeier C (1995) Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699-705
29. Scotlandi K, Baldini N, Oliviero M, Di Renzo MF, Martano M, Serra M, Manara MC, Comoglio PM, Ferracini R (1996) Expression of met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. Am J Pathol 149:1209-1219
30. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ (1997) Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res 57:433-439
31. Takayama H, LaRochelle WJ, Anver M, Bookman DE, Merlino G (1996) Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci USA 93:5866-5871
32. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G (1997) Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94:701-706
33. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF (1992) The met proto-oncogene receptor and lumen formation. Science 257:1258-1261
34. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88:7001-7005
35. Wiethege T, Voss B, Pohle T, Fisseler-Eckhoff A, Müller KM (1991) Localization of elastase and tumor necrosis factor alpha mRNA by non-radioactive in situ hybridization in cultures of alveolar macrophages. Pathol Res Pract 187:912-915
36. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, Shin S (1994) Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54:1630-1633